Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH

Wang, JP; Cho, NL; Zauber, AG; Hsu, M; Dawson, D; Srivastava, A; Mitchell-Richards, KA; Markowitz, SD; Bertagnolli, MM

Bertagnolli, MM (reprint author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018; 27 (7): 728

Abstract

Background: The Adenoma Prevention with Celecoxib (APC) Trial showed that cyklooxygenase-2 (Cox 2) inhibitor, celecoxib, decreased adenoma development......

Full Text Link